On January 28, 2019, scPharmaceuticals Inc. and Troy Ignelzi, the company's Chief Financial Officer (and principal financial and accounting officer) agreed to end Mr. Ignelzi's employment with the company and its subsidiaries effective February 28, 2019 (the Effective Date). On January 28, 2019, the board appointed Rachael Nokes to succeed Mr. Ignelzi as the company's principal accounting officer and John Tucker to succeed Mr. Ignelzi as the company's principal financial officer, in each case effective as of the Effective Date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 USD | -1.55% | +6.03% | -24.24% |
May. 14 | Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.24% | 171M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- SCPH Stock
- News scPharmaceuticals Inc.
- ScPharmaceuticals Inc. Announces Management Changes